Bicycle Therapeutics Plc (BCYC)

5.24 -0.12 (-2.24%) USD  |  NASDAQ  |  Feb 13, 15:56
More

Bicycle Therapeutics Free Cash Flow : -242.07M for Sept. 30, 2025

Free Cash Flow Chart

View Free Cash Flow for BCYC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
Biodexa Pharmaceuticals Plc -14.30M
NuCana Plc -18.19M
Mereo BioPharma Group Plc -33.02M
Autolus Therapeutics Plc -306.93M
DBV Technologies SA -98.65M

Free Cash Flow Related Metrics

Cash from Operations (Quarterly) -70.63M
Cash from Investing (Quarterly) -0.6709M
Cash from Financing (Quarterly) -0.0297M
Free Cash Flow Per Share (Quarterly) -1.029
Free Cash Flow to Equity (Quarterly) -69.80M
Free Cash Flow to Firm (Quarterly) -71.27M
Free Cash Flow Yield -66.76%